2023
DOI: 10.1039/d3dt00977g
|View full text |Cite
|
Sign up to set email alerts
|

Effect of metal complexation on the radiolytic stability of DOTA

Ilyes Mahti,
Dominique Guillaumont,
Claude Berthon
et al.

Abstract: Radiometals are increasingly used in nuclear medicine for both, diagnostic and therapeutic purposes. DOTA ligand (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) is widely used as a chelating agent for various radionuclides, including 89Zr, with...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 92 publications
0
2
0
Order By: Relevance
“…Atom C5 is in the vicinity of two electronegative atoms, and a change in electron density during protonation and deprotonation affects its NBO charge. The proposed methodology can be applied to predicting the reactive sites in newly obtained ligands [42]. A molecular electrostatic potential (MEP) map is a way to predict reactive sites for noncovalent interactions [43,44].…”
Section: Theoretical Structural and Reactivity Analysis Of Plagmentioning
confidence: 99%
“…Atom C5 is in the vicinity of two electronegative atoms, and a change in electron density during protonation and deprotonation affects its NBO charge. The proposed methodology can be applied to predicting the reactive sites in newly obtained ligands [42]. A molecular electrostatic potential (MEP) map is a way to predict reactive sites for noncovalent interactions [43,44].…”
Section: Theoretical Structural and Reactivity Analysis Of Plagmentioning
confidence: 99%
“…We designed a novel trifunctional chelating agent composed of a 1,4,7,10-tetr aazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) derivative as a chelator to coordinate a radiometal, a CTSB substrate to conjugate with CTSB, and an azide group to be introduced into mAb, that is, azide-DOTA-CTSB substrate (ADCS) (Figure 1A). DOTA is a suitable chelator for application to RICs with long biological half-lives in blood, as there have been reports on the stable coordination of DOTA with radionuclides with long halflives, such as 111 In (2.8 days) and 89 Zr (3.3 days) for diagnosis and 177 Lu (6.6 days) and 225 Ac (9.9 days) for therapy [14][15][16][17]. A DOTA derivative with one carboxy group and one amino group was reported as a favorable chelator to introduce functional units [18].…”
Section: Introductionmentioning
confidence: 99%